BioSpace News Archive

Adverum Biotechnologies, Inc. is presenting data from the INFINITY clinical trial of ADVM-022 in patients with diabetic macular edema during the American Society of Retina Specialists 39th Annual Scientific Meeting and will be presenting an encore presentation of long-term data from the OPTIC trial of ADVM-022 for wet AMD on Monday, October 11, 2021 at 8:50 am CT.

REGENXBIO Inc. announced initial data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy without center-involved diabetic macular edema using in-office suprachoroidal delivery.